Fatigue as a residual symptom of depression

Innovations in Clinical Neuroscience

Volumn 8, Issue 10, 2011, Pages 40-43

  Targum, Steven D ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATOMOXETINE; METHYLPHENIDATE; MODAFINIL; NORADRENALIN UPTAKE INHIBITOR; PROTRIPTYLINE; REBOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPLE REUPTAKE INHIBITOR;

ACADEMIC ACHIEVEMENT; APATHY; ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; DEPRESSION; DRUG INDUCED DISEASE; DRUG RESPONSE; EMOTION; EMOTIONAL DISORDER; FAMILY RELATION; FATIGUE; FUNCTIONAL STATUS; HEALTH CARE UTILIZATION; HUMAN; JOB PERFORMANCE; MAJOR DEPRESSION; MEDICAL HISTORY; RESIDUAL FATIGUE; SOCIAL INTERACTION; SYMPTOM; TREATMENT EMERGENT DEPRESSION; TREATMENT EMERGENT FATIGUE;

EID: 82755182036     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60:221-225.
2. Fava M. Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment. J Clin Psychiatry. 2003;64(suppl 14):30-34.
3. Demyttenaere K, Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder. Int J Neuropharmacol. 2004;8:93-105.
4. Ferrentinos P, Kontaxakis V, Havaki-Kontaxaki B, et al. The Fatigue Questionnaire: standardization in patients with major depression. Psychiatry Res. 2010;177(1):114-119.
5. Arnold LM. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics. 2008;49:185-190.
6. Chandler GM, Iosifescu D, Pollack M, et al. Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Therapeut. 2010;16(5):322-325.
7. Phillips GA, Matza LS, Murray L, Revicki DA. Reliability and validity of the fatigue associated with depression questionnaire (FAsD): an interim analysis. Eur J Neurol. 2009;16(suppl 3):460.
8. Fava M, Iosifescu DV, Pedrelli P, Baer L. Reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire. Psychother Psychosom. 2009;78:91-97.
9. Targum SD, Hassman H, Pinho M, Fava M. Validation of a global assessment measure for fatigue. Presented at the 51st Annual NCDEU Meeting. Boca Raton FL: June 14, 2011.
10. Papakostas GI, Nutt DJ, Hallett LA, et al. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry. 2006;60(12):1350-1355.
11. Baldwin DS, Papakostas GI. Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry. 2006;67(Suppl 6):9-15.
12. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry. 2005;66(1):85-93.
13. Chang T, Fava M. The future of psychopharmacology of depression. J Clin Psychiatry. 2010;71(8):971-975.